Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (ACTRN12625000847415) titled 'A Study of Quantum Salt-Enhanced (QSE) Phototherapy for Type 1 Diabetes' on Aug. 6.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Non-randomised trial
Masking: Open (masking not used)
Assignment: Single group
Type of endpoint: Efficacy
Primary Sponsor: Quantech Group Limited
Condition:
Type 1 Diabetes Mellitus
Type 1 Diabetes Mellitus
Metabolic and Endocrine - Diabetes
Intervention:
Participants will receive daily 30-minute sessions of Quantum Salt-Enhanced (QSE) phototherapy for 15 to 21 consecutive days, depending on individual tolerance and scheduling adherence. The interven...